FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1129811000001104: Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22603901000001115 Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22604001000001117 Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Is pack of Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has active ingredient Ampicillin sodium false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has active ingredient Ampicillin false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has VMP Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has specific active ingredient Ampicillin sodium true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnapen 500mg powder for solution for injection vials (C P Pharmaceuticals Ltd) 10 vial Is a True Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Inferred relationship Existential restriction modifier
Co-fluampicil 250mg/250mg powder for solution for injection vials (Wockhardt UK Ltd) 10 vial Is a True Co-fluampicil 250mg/250mg powder for solution for injection vials 10 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start